Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemogenomics in drug discovery.

Ernst Schering Research Foundation workshop - 1 Jan 2006

Kubinyi H

Abstract excerpt

Chemogenomics is a new strategy in drug discovery which, in principle, searches for all molecules that are capable of interacting with any biological target. Because of the almost infinite number of drug-like organic molecules, this is an impossible task. Therefore chemogenomics has been defined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Molecular Structure
Share to Chemistry, Pharmaceutical
Share to Combinatorial Chemistry Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Drug Industry

Share to Genomics

Share to Models, Chemical

Share to Pharmacogenetics

Source

Identifiers

PMID: 16708995
DOI: 10.1007/978-3-540-37635-4_1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16708995-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemogenomics in drug discovery.PMID 16708995Read ↗

Applications of chemogenomic library screening in drug discovery.Semantic proximity Read ↗

Natural products as probes in pharmaceutical research.Semantic proximity Read ↗

Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space.Semantic proximity Read ↗

Current Screening Methodologies in Drug Discovery for Selected Human DiseasesSemantic proximity Read ↗

Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery.Semantic proximity Read ↗

Chemo‐proteomics in antimalarial target identification and engagementSemantic proximity Read ↗

Aggregated Compound Biological Signatures Facilitate Phenotypic Drug Discovery and Target Elucidation.Semantic proximity Read ↗

Connecting phenotype and chemotype: high-content discovery strategies for natural products research.Semantic proximity Read ↗

Phenocopy--a strategy to qualify chemical compounds during hit-to-lead and/or lead optimization.Semantic proximity Read ↗

Chemoproteomic-enabled phenotypic screening.Semantic proximity Read ↗

Phenotyping drug polypharmacology via eicosanoid profiling of blood.Semantic proximity Read ↗

GPCR profiling: from hits to leads and from genotype to phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.